Following the company’s fourth quarter results, Leede Financial analyst Douglas Loe has upgraded Cipher Pharmaceuticals (Cipher Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:CPH). ON March 18, CPH reported its Q4 and fiscal 2024 results. In the fourth quarter, the company posted Adjusted EBITDA of $5.0-million on revenue of $11.8-million, a topline that wasup 141%, […]
Following a notable acquisition, RBC analyst Douglas Miehm has raised his price target on Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News, Analysts, Financials TSX:GUD). On March 11, GUD announced that it had agreed to acquire the assets of Paladin Pharma for $120-million. “The reunion of Paladin and Knight, two companies dear to me, is […]
Share
Tweet
Share
